158 related articles for article (PubMed ID: 36165231)
41. Isoliquiritigenin Inhibits Oral Squamous Cell Carcinoma and Overcomes Chemoresistance by Destruction of Survivin.
Zhou Z; Han S; Liao J; Wang R; Yu X; Li M
Am J Chin Med; 2023; 51(8):2221-2241. PubMed ID: 37930332
[TBL] [Abstract][Full Text] [Related]
42. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
43. Elevated autocrine chemokine ligand 18 expression promotes oral cancer cell growth and invasion via Akt activation.
Jiang X; Wang J; Chen X; Hong Y; Wu T; Chen X; Xia J; Cheng B
Oncotarget; 2016 Mar; 7(13):16262-72. PubMed ID: 26919103
[TBL] [Abstract][Full Text] [Related]
44. Circ-PKD2 promotes Atg13-mediated autophagy by inhibiting miR-646 to increase the sensitivity of cisplatin in oral squamous cell carcinomas.
Gao L; Zhang Q; Li S; Zheng J; Ren W; Zhi K
Cell Death Dis; 2022 Feb; 13(2):192. PubMed ID: 35220397
[TBL] [Abstract][Full Text] [Related]
45. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
46. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
Chen L; Zhu Q; Lu L; Liu Y
Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
[TBL] [Abstract][Full Text] [Related]
47. Down-regulation of Akt by methanol extracts of Impatiens balsamina L. promotes apoptosis in human oral squamous cell carcinoma cell lines.
Shin JA; Ryu MH; Kwon KH; Choi B; Cho SD
J Oral Pathol Med; 2015 Jul; 44(6):420-8. PubMed ID: 25212570
[TBL] [Abstract][Full Text] [Related]
48. Mcl-1 is an important therapeutic target for oral squamous cell carcinomas.
Maji S; Samal SK; Pattanaik L; Panda S; Quinn BA; Das SK; Sarkar D; Pellecchia M; Fisher PB; Dash R
Oncotarget; 2015 Jun; 6(18):16623-37. PubMed ID: 26009874
[TBL] [Abstract][Full Text] [Related]
49. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
[TBL] [Abstract][Full Text] [Related]
50. As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
Liu S; Gao W; Lu Y; Zhou Q; Su R; Hasegawa T; Du J; Li M
Int J Biol Sci; 2022; 18(2):491-506. PubMed ID: 35002505
[TBL] [Abstract][Full Text] [Related]
51. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L
Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838
[TBL] [Abstract][Full Text] [Related]
52. Fat mass and obesity-associated protein regulates arecoline-exposed oral cancer immune response through programmed cell death-ligand 1.
Li X; Chen W; Gao Y; Song J; Gu Y; Zhang J; Cheng X; Ai Y
Cancer Sci; 2022 Sep; 113(9):2962-2973. PubMed ID: 35289035
[TBL] [Abstract][Full Text] [Related]
53. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma.
Tavares MO; Milan TM; Bighetti-Trevisan RL; Leopoldino AM; de Almeida LO
J Oral Pathol Med; 2022 Jul; 51(6):529-537. PubMed ID: 35678235
[TBL] [Abstract][Full Text] [Related]
54. Melatonin enhances cisplatin-induced cell death through inhibition of DERL1 in mesenchymal-like CD44
Shigeishi H; Yokoyama S; Murodumi H; Sakuma M; Fukada S; Okuda S; Yamakado N; Ono S; Takechi M; Ohta K
J Oral Pathol Med; 2022 Mar; 51(3):281-289. PubMed ID: 34551150
[TBL] [Abstract][Full Text] [Related]
55. SARI inhibits growth and reduces survival of oral squamous cell carcinomas (OSCC) by inducing endoplasmic reticulum stress.
Priyadarshini M; Maji S; Samal SK; Rath R; Li J; Das SK; Emdad L; Kundu CN; Fisher PB; Dash R
Life Sci; 2021 Dec; 287():120141. PubMed ID: 34774620
[TBL] [Abstract][Full Text] [Related]
56. CMTM6 promotes cell proliferation and invasion in oral squamous cell carcinoma by interacting with NRP1.
Zheng Y; Wang C; Song A; Jiang F; Zhou J; Li G; Zhang W; Ye J; Ding X; Zhang W; Du Y; Zhang H; Wu H; Song X; Wu Y
Am J Cancer Res; 2020; 10(6):1691-1709. PubMed ID: 32642284
[TBL] [Abstract][Full Text] [Related]
57. Protein Kinase D3 Promotes the Reconstruction of OSCC Immune Escape Niche Via Regulating MHC-I and Immune Inhibit Molecules Expression.
Lv D; Chen J; Kang Y; Luo M; Chen H; Cui B; Wang L; Wang J; Zhou X; Feng Y; Huang L; Zhang P
J Immunother; 2021 Nov-Dec 01; 44(9):339-347. PubMed ID: 34545012
[TBL] [Abstract][Full Text] [Related]
58. Cancer stemness of CD10-positive cells regulated by Hedgehog pathway promotes the resistance to cisplatin in oral squamous cell carcinoma.
Wang Y; Li Q; Xu L; Chen J; Pu Y; Wang L; Sun H; Guo Y; Guo C
Oral Dis; 2021 Sep; 27(6):1403-1411. PubMed ID: 33037760
[TBL] [Abstract][Full Text] [Related]
59. Candida albicans induces upregulation of programmed death ligand 1 in oral squamous cell carcinoma.
Wang X; Zhao W; Zhang W; Wu S; Yan Z
J Oral Pathol Med; 2022 May; 51(5):444-453. PubMed ID: 35362187
[TBL] [Abstract][Full Text] [Related]
60. Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer.
Alam M; Mishra R
Life Sci; 2021 Sep; 280():119705. PubMed ID: 34111459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]